Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9327362 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
In a gynecologic oncology patient with high clinical suspicion for PE, our clinical pre-test probability was 23.0%. Two-year mortality rates were 6-fold higher for patients diagnosed with PE. The significant overlap in clinical presentations, multiple risk factors and higher mortality rates encourage the aggressive diagnosis and treatment of PE among this population. Further work is needed to reduce the incidence and mortality rate of PE.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Martin A. Martino, Eva Williamson, Sylvia Siegfried, Richard J. Cardosi, Alan B. Cantor, Mitchel S. Hoffman, James V. Fiorica,